The impact of universal access to DAA and real-world treatment outcome amongst genotype 3 hepatitis C virus-infected prisoners

被引：0
|
作者：
Wong, Yu Jun [1 ]
Manejero, Fria May Gloriba [1 ]
Lim, Kim Wei [1 ]
Chong, Sin Yoong [1 ]
Mai, Linn War [1 ]
Kumar, Rahul [1 ]
Teo, Eng Kiong [1 ]
Tan, Jessica [1 ]
Hsiang, John Chen [2 ]
Thurairajah, Prem Harichander [1 ]
机构：
[1] Changi Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore
[2] Sengkang Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU354
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [21] A real-world study on the effectiveness of elbasvir/grazoprevir in the treatment of genotype 1 chronic hepatitis C
    李宽
    China Medical Abstracts(Internal Medicine), 2021, 38 (02) : 109 - 109
  • [22] Real-World Evaluation of the Economic Impact of Duration of Drug Therapy in the Treatment of Hepatitis C Virus (HCV): an Update
    McCombs, Jeffrey S.
    Shin, Janet
    Hines, Patricia
    Saab, Sammy
    Yuan, Yong
    GASTROENTEROLOGY, 2012, 142 (05) : S1011 - S1011
  • [23] Efficacy and safety of sofosbuvir/velpatasvir in a real-world chronic hepatitis C genotype 3 cohort
    Wong, Yu Jun
    Thurairajah, Prem Harichander
    Kumar, Rahul
    Tan, Jessica
    Fock, Kwong Ming
    Law, Ngai Moh
    Li, Weiquan
    Kwek, Andrew
    Tan, Yu Bin
    Koh, Jingyun
    Lee, Zheng Cong
    Kumar, Loshini Senthil
    Teo, Eng Kiong
    Ang, Tiing-Leong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (05) : 1300 - 1308
  • [24] Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection
    Cornberg, M.
    Petersen, J.
    Schober, A.
    Mauss, S.
    Boeker, K. H. W.
    Link, R.
    Guenther, R.
    Serfert, Y.
    Pfeiffer-Vornkahl, H.
    Manns, M. P.
    Sarrazin, C.
    Hueppe, D.
    Berg, T.
    Niederau, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (05) : 688 - 700
  • [25] Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings
    Rosati, Silvia
    Wong, Alexander
    Di Marco, Vito
    Perez-Hernandez, Paco
    Macedo, Guilherme
    Brixko, Christian
    Ranieri, Roberto
    Campanale, Francesca
    Bascia, Annalisa
    Fernandez-Rodriguez, Conrado
    de Ledinghen, Victor
    Maida, Ivana
    Teti, Elisabetta
    Mangia, Alessandra
    Vanstraelen, Kim
    Hernandez, Candido
    Mertens, Michael
    Ntalla, Ioanna
    Ramroth, Heribert
    Jimenez, Elena
    FUTURE VIROLOGY, 2022, 17 (07) : 419 - 428
  • [26] The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
    Wong, Yu Jun
    Thurairajah, Prem Harichander
    Kumar, Rahul
    Fock, Kwong Ming
    Law, Ngai Moh
    Chong, Sin-Yoong
    Manejero, Fria Gloriba
    Ang, Tiing-Leong
    Teo, Eng Kiong
    Tan, Jessica
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (03) : 474 - 485
  • [27] Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real-world setting
    Siederdissen, Christoph Hoener Zu
    Buggisch, Peter
    Boeker, Klaus
    Schott, Eckart
    Klinker, Hartwig
    Pathil, Anita
    Pfeiffer-Vornkahl, Heike
    Berg, Thomas
    Sarrazin, Christoph
    Hueppe, Dietrich
    Manns, Michael P.
    Mauss, Stefan
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (02) : 213 - 224
  • [28] Effectiveness of ledipasvir/sofosbuvir in hepatitis C virus genotype 1, 2 and 3 infection: real-world data from Georgian hepatitis C elimination program
    Tsertsvadze, Tengiz
    Chkhartishvili, Nikoloz
    Abutidze, Akaki
    Sharvadze, Lali
    Kerashvili, Vakhtang
    Butsashvili, Maia
    Zarkua, Jaba
    Gvinjilia, Lia
    Nasrullah, Muaz-Zam
    Gamkrelidze, Amiran
    Kvaratskhelia, Valeri
    Afdhal, Nezam H.
    Arora, Sanjeev
    Zeuzem, Stefan
    Thornton, Karla A.
    Averhoff, Francisco
    HEPATOLOGY, 2017, 66 : 855A - 855A
  • [29] Real-World Retreatment of Sofosbuvir/Ledipasvir (SOF/LDV) Failures In Hepatitis C Virus Genotype 1 infection
    Pearlman, Brian
    Hinds, Andrew
    Perrys, Michael
    HEPATOLOGY, 2016, 64 : 478A - 478A
  • [30] Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
    Crespo, Javier
    Luis Calleja, Jose
    Fernandez, Inmaculada
    Sacristan, Begona
    Ruiz-Antoran, Belen
    Ampuero, Javier
    Hernandez-Conde, Marta
    Garcia-Samaniego, Javier
    Gea, Francisco
    Buti, Maria
    Cabezas, Joaquin
    Lens, Sabela
    Maria Morillas, Rosa
    Ramon Salcines, Jose
    Manuel Pascasio, Juan
    Turnes, Juan
    Saez-Royuela, Federico
    Arenas, Juan
    Rincon, Diego
    Prieto, Martin
    Jorquera, Francisco
    Sanchez Ruano, Juan Jose
    Navascues, Carmen A.
    Molina, Esther
    Gallego Moya, Adolfo
    Maria Moreno-Planas, Jose
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (06) : 945 - 949
12345